We report the identification and characterization of a novel lipid kinase that phosphorylates multiple substrates. This enzyme, which we term MuLK for Multi Lipid Kinase, does not belong to a previously described lipid kinase family. MuLK has orthologs in many organisms and is broadly expressed in human tissues. Although predicted to be a soluble protein, MuLK cofractionates with membranes and localizes to an internal membrane compartment. Recombinant MuLK phosphorylates diacylglycerol, ceramide and 1-acyl-glycerol but not sphingosine.
Introduction
The membranes of eukaryotic organelles contain a shifting constellation of lipids that, in addition to their structural role, also serve as modulators of protein function, scaffolding molecules and ligands for G protein-coupled receptors. The generation, phosphorylation, and dephosphorylation of mono-and diacylglycerols (DG), sphingosine, and ceramide produce signaling lipids that modulate a vast array of cellular processes (1) (2) (3) (4) (5) . In animal cells, the kinases that act on DG (6), ceramide (7) and sphingosine (8) constitute three different families of enzymes, each of which demonstrates substrate selectivity. In contrast, E. coli expresses a lipid kinase that phosphorylates all three substrates (9) . Although animal cell lipid kinases are specific and clearly belong to distinct families based on their amino acid sequences, they share a similar catalytic domain that was first identified in DG kinase a (10) and is therefore known as a DG kinase domain.
Sequencing of the human and mouse genomes has revealed multiple putative lipid kinases, several of which contain a DG kinase domain. In an attempt to identify cDNAs encoding a calcium-activated ceramide kinase that co-purifies with neurotransmitter-containing (synaptic) vesicles (11), we searched sequence databases for orphan lipid kinases that might encode a ceramide kinase. We report here the characterization of a lipid kinase that phosphorylates ceramide but also demonstrates significant activity toward DG and monoacylglycerols. This enzyme, which we term MuLK for multi-substrate lipid kinase, is a novel lipid kinase.
5 genes. However, the search also revealed a gene with a region that is 44% homologous to hSPK2. The region of highest homology corresponded to a potential kinase catalytic domain that is present in both sphingosine and DG kinases. This highest scoring sequence was used in a BLASTP search of the non-redundant protein database, which revealed three unpublished entries. One entry was identified as a putative lipid kinase, but did not describe any functional data. The full-length protein sequence of the putative lipid kinase was then used to re-query the human genome database and three homologous sequences were identified.
Sequence comparisons and domain predictions -The sequences of MuLK, CERK, sphingosine and DG kinases were aligned using ClustalW with the BLOSUM protein weight matrix. A phylogenetic tree was constructed and genetic distances calculated (percent divergence) using the neighbor joining method of Saitou and Nei (12) were identified using a BLASTP search and compared to human and mouse MuLK sequences using ClustalW. ClustalW identifies conservative changes by dividing amino acid residues into MuLK-EGFP expression and subcellular fractionation -A carboxy-terminal fusion of enhanced green fluorescent protein to MuLK (MuLK-EGFP) was generated by ligating an EGFP PCR product into Sal I and Not I sites of a plasmid already containing MuLK. This effectively eliminated the intervening IRES and generated the desired fusion construct. To create the Cterminal fusion of EGFP to CERK, CERK was amplified using PCR from IMAGE clone 6400872 (Invitrogen) and inserted into EcoR1/Sal1 sites of the pMuLK-EGFP construct, replacing MuLK. To evaluate cellular localization, a 60 cm plate of 80% confluent HEK293T cells was transfected with 1.6 ug of DNA of each construct (pIRES-EGFP, pMuLK-EGFP, and pCERK-EGFP) using Lipofectamine 2000. A transfection efficiency of 60-70% was determined by fluorescent microscopy. After 48 hours, cells were washed with ice-cold PBS and scraped into PBS containing 2 mg/ml aprotinin, 0.5 mg/ml leupeptin, 0.7 mg/ml pepstatin and 0.2 mM PMSF, and then lysed by sonication. Intact cells and nuclei were removed by centrifuging 2000xg for 5 min. Soluble and insoluble fractions of the cleared lysate were then generated by ultracentifugation at 100,000xg for 1 hour at 4°C. Equal volumes of these samples were separated on a 12.5% Tris-Glycine gel under reducing and denaturing conditions and then transferred to PVDF. Blots were probed with monoclonal anti-GFP (B-2) antibody, followed by HRP-conjugated goat-anti-mouse secondary antibody and detected using the Pierce DuraWest enhanced chemiluminescence reagent. To visualize MuLK-EGFP expression in situ, transfected cells were fixed 48 hours after transfection (4% paraformaldehyde for 20 min), washed 3 times in 0.1 M glycine, incubated with Hoechst dye to label nuclei and coverslipped using Fluoromount G as a mounting medium. EGFP fluorescence was visualized using an Applied Precision Deltavision microscope and images were captured using Softworx software.
mRNA expression analysis -To determine expression levels of MuLK in various human tissues a 528 base pair product, encompassing the 3' end of the coding sequence and 119 base pairs of the 3' untranslated region of human MuLK, was amplified from a BD Biosciences normalized cDNA panel. Reactions were conducted according to the manufacturer's directions. The following two 29 base pair primers were used; 5' -GGCACAACCACAGGATGCCCTTTCCCAAG; 3' -TGCCATGAAAATGCCCTGGGGACCCTCTG. MuLK reactions were incubated at 94°C for 30s and followed by 28 cycles of 94° C for 5 sec and 68° C for 2 min. As a control for template loading, a portion of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was also amplified using manufacturer-supplied primers and cycle parameters. The relative amounts of GAPDH product generated from each tissue were similar to the levels reported by the manufacturer. PCR products were separated in a 2% agarose gel and stained with ethidium bromide. Product band net intensity was quantified on a Kodak Image Station 440CF.
Expression of C-terminal FLAG-tagged
MuLK --A carboxy-terminal FLAG-epitope-tagged mouse MuLK (MuLK-FLAG) was created by inserting MuLK into pFLAG-CTC. This construct was expressed in BL21, a protease-deficient strain of E. coli. To generate protein, cultures of transformed bacteria were grown under selection overnight, diluted 10-fold and then grown to an A 600 of 2 at which point protein expression was induced by adding 100 mM IPTG for four hours.
After induction, bacteria were harvested by centrifugation, resuspended in ice cold 10 mM MOPS, pH 7.2, containing 25 mM NaCl, 1 mM EGTA and protease inhibitors (1 pellet/10 ml buffer) and probe sonicated. The lysate was centrifuged at 20,000 x g for 20 min and the pFLAG-CTC fusion protein, which served as a negative control, was generated and purified using an identical procedure. Glycerol or ethylene glycol, and dithiothreitol were added to the eluate to a final concentration of 20% vol/vol and 1 mM, respectively. For kinetic assays, the recombinant protein was stored at 4 o C and used within a week. Expression and purification of a 47 KDa protein was confirmed by Western analysis using the anti-FLAG M2 antibody.
Expression levels of MuLK in E. coli varied between preparations and protein yields were generally low.
Lipid kinase activity assay -The activity of purified, recombinant mouse MuLK was assayed in b-octylglucoside as previously described (13) proportional to added enzyme, and substrate conversion was less than two percent. Calcium concentrations were calculated using the MaxChelator Program (http://www.stanford/edu/~cpatton/webmaxcS.htm)). Kinetic parameters were calculated using Prism Graph Pad software.
Results

Identification of two novel lipid kinases by homology searching
Based on the hypothesis that ceramide kinases would share structural and functional domains with sphingosine kinase, we performed a database search using one of the human sphingosine kinases, sphingosine kinase 2, as a query sequence as described under Experimental
Procedures. This search revealed a gene that contained both a region that is 44% homologous to SPK2 and a potential lipid kinase catalytic domain that is present in sphingosine and DG kinases (14) . The predicted full-length protein encoded by this gene was obtained from a BLASTP search. As described below, we have named this protein MuLK. The sequence of MuLK was then used to re-query the human genome database. Three additional gene sequences were identified. All three are distantly related to sphingosine and DG kinases, with sequence homologies of 10-22%. One of these was recently described by Sugiura, et al., as a ceramidespecific kinase which they have termed CERK (7) . The other two shared 68-87% amino acid sequence identity with MuLK. These three proteins therefore appeared to constitute a gene family. A BLASTP search using human MuLK as a query sequence revealed a mouse homolog as well as putative homologs in multiple organisms.
The sequence of MuLK in HEK293T cells and compared the proportion of MuLK in the cytosolic and membrane fractions as described under Experimental Procedures. As a control for the effects of EGFP on protein localization, we also analyzed the localization of mouse CERK-EGFP, since untagged CERK was previously shown to be largely membrane-associated (7). Western analyses of cytosolic and membrane fractions revealed that the majority of MuLK was found in the particulate fraction (100,000 x g pellet), a distribution similar to that of CERK. EGFP, expressed alone, was largely cytosolic (Figure 3A) . When expressed in Chinese Hamster Ovary cells, a fibroblast cell line, MuLK-EGFP localized to an internal membrane compartment ( Figure 3B ).
This indicates that in unstimulated fibroblasts the enzyme is associated with endomembranes rather than being cytoplasmic or nuclear as suggested by its sequence.
To determine the tissue distribution of MuLK, we surveyed RNA expression levels by amplification of normalized cDNA pools from various tissues as described under Experimental
Procedures. Figure 4 shows that MuLK was expressed in all tissues surveyed. Expression was highest in neuroendocrine organs, such as pancreas and brain, and relatively lowest in skeletal muscle, kidney, and lung.
MuLK is a multi-substrate lipid kinase.
To determine whether MuLK is a bona fide lipid kinase and to test its substrate specificity, we analyzed the ability of recombinant MuLK to phosphorylate various lipids in vitro using an assay in which substrates were presented in detergent-lipid mixed micelles. Purified recombinant MuLK-FLAG phosphorylated 1, 2-dioleoyl-sn-glycerol as well as monoacylglycerols. It also demonstrated significant activity towards ceramide but not sphingosine ( Figure 5A ). This indicates that MuLK can phosphorylate a number of neutral lipid species but does exhibit some substrate selectivity. We have indirect evidence that MuLK does not phosphorylate soluble polyols, since up to 20% (vol/vol) glycerol or ethylene glycol had no effect on its ceramide kinase activity (not shown). MuLK phosphorylated sn1-oleoylglycerol and 1-arachidonoylglycerol (1-AG) to a similar extent. It showed little activity toward 2-arachidonoylglycerol (2-AG) when the assay was conducted using Triton X-100 mixed micelles ( Figure 4A ), however when kinase selectivity was assessed using b-octylglucoside mixed micelles, a greater relative activity toward 2-AG was detected (not shown). Despite these observations, we cannot be certain that 2-AG is a bona fide substrate since preparations of 2-AG readily isomerize to 1-AG (19) .
To confirm that the activity measured was not due to contaminating E. coli DG kinase, an unrelated recombinant protein, SV2AN, purified in the same way as recombinant MuLK-FLAG was assayed for lipid kinase activity. It exhibited minimal activity, indicating that MuLK was responsible for the majority of the kinase activity measured (not shown).
MuLK DG kinase activity was inhibited 86-94% by the presence of 40-fold higher concentrations of alternate substrates ( Figure 5B ). Assuming only one active site on MuLK, this inhibition, together with the finding that MuLK phosphorylates ceramide, mono-and diacylglycerols, suggests that MuLK's substrates act as competitive inhibitors of one another.
Interestingly, sphingosine also inhibited DG kinase activity ( Figure 5B ), even though it was not a substrate for the enzyme. Both ceramide and DG kinase activities were inhibited by sphingosine in a dose-dependent manner (not shown).
MuLK demonstrates similar affinities for ceramide and DG but a higher Vmax toward DG.
To analyze further the substrate specificity of MuLK, we measured the apparent K m and V max towards ceramide and DG in two different detergent-based assays. Using the boctylglucoside-based assay previously used to assay ceramide kinase activity (13) we found a trend towards a slightly lower K m for ceramide and a consistently higher V max for DG (not shown). In a Triton X-100-based assay the apparent K m for ceramide (34 uM) again was slightly lower but was similar to that for DG (45 uM) suggesting that the enzyme binds both lipids with roughly equal affinity. Similar K m values were determined for dipalmitoylglycerol in TX-100
(not shown), suggesting that acyl chain length does not have significant effects on substrate affinity. In this assay the V max for dioleoylglycerol (159 nmol/min/mg) was 4-5 times the rate measured for ceramide (37 nmol/min/mg) ( Figure 6A) .
We also performed assays in which we varied the mol% of substrate in Triton X-100 micelles. Data derived in this manner can be compared to a surface dilution kinetic model (20) .
We found that ceramide kinase activity conformed to such a model, yielding a K m of 3.78 mol% and a V max of 68 nmol/min/mg protein ( Figure 6B) . By contrast, the K m for dioleoylglycerol was independent of the surface concentrations tested, suggesting that it was too low to measure ( Figure 6C ). These results were not an aberration of the assay system since surface dilution kinetic parameters for a DG kinase activity from T-cells has been determined using similar conditions (D. Waggoner, unpublished observations). These results highlight the sensitivity of MuLK to substrate presentation and suggest that the affinities and kinetics measured in vitro using recombinant enzyme may differ from those of the enzyme in vivo.
MuLK activity is modulated by surface charge and the ionic environment.
Kinases require a counter ion for ATP, typically Mg 2 . In some cases kinase activity is also modulated by those same ions directly. DG kinases from E. coli (21) and pig brain (22) are both stimulated by magnesium in excess of ATP concentrations. We examined the Mg requirement for MuLK's DG and ceramide kinase activities and found that it stimulated MuLK kinase activity maximally when included at 5-10 molar excess over ATP (not shown).
All reported endogenous ceramide kinase activities, as well as the recently identified ceramide-specific kinase, CERK, are stimulated by Ca 2+ (7, 11, 23, 24 Cardiolipin has been reported to be an activator of E. coli DG kinase (9) and for that reason was included in the assay. We found that MuLK required the presence of cardiolipin in detergent micelles for ceramide kinase activity (not shown). Moreover, the stimulatory effect of cardiolipin was concentration dependent for both ceramide and DG kinase activity and was most dramatic at low Ca 2+ concentrations (Figure 7 ). Together these findings indicate that MuLK activity is influenced by the ionic environment and by the charge of the lipid surface.
Discussion
We have described a novel lipid kinase that differs from known lipid kinases not only in sequence but also by demonstrating a broad substrate preference. Some DG kinases also phosphorylate monacylglycerols (25) but little to no detectible ceramide kinase activity has been reported for any of the isoforms ( (26, 27) and H. Kanoh, personal communication). Analogously, the ceramide kinase CERK displays no activity toward DG (7). The only other lipid kinase with the broad substrate specificity of MuLK is E. coli DG kinase (9) (for review see (28)).
Therefore, MuLK's broad substrate selectivity appears to be unique among eukaryotic lipid kinases. MuLK orthologs were found in many eukaryotes ranging from plants to human, and it is expressed in all human tissues surveyed. This suggests that MuLK provides an important function that is required by all cells. We found no MuLK homologs in yeast, however, consistent with its function being subsumed by another enzyme in lower eukaryotes.
MuLK activity demonstrates complex regulation.
The effects of lipids, detergents and ions on MuLK activity suggest that its action in vivo is likely to be under complex regulation, a feature MuLK shares with other lipid kinases. The requirement for, and stimulatory effect of cardiolipin parallels the effects of anionic lipids on E.
coli DG kinase (21, 29) , and eukaryotic DG kinases a (30,31) and z (32), and contrasts with inhibitory effects on other isoforms (10, 27, 32, 33) . The cationic lipid sphingosine, which exhibits both stimulatory and inhibitory effects on different DG kinase isoforms (34-37) potently inhibits MuLK activity. We originally hypothesized that sphingosine acts as a competitive inhibitor of MuLK, however inhibition was not stereospecific and was sensitive to the concentration of cardiolipin in the assay (not shown) suggesting sphingosine's inhibitory action is more complex and may include charge neutralization at the lipid (substrate) surface.
We found that Ca 2+ could either stimulate or inhibit MuLK activity, depending on the concentrations of Mg 2+ and cardiolipin in the reaction. Similar reciprocal magnesium-dependent effects have been reported for PI3K (37) , and calcium effects on DG kinase a vary with reaction conditions and are phosphatidylserine-dependent (33 
Is MuLK a chameleon kinase?
The activity of MuLK in vitro was greatest toward DG, suggesting that it may act primarily as a DG kinase in vivo. On the other hand, given that detergents, lipids and ionic conditions critically affect MuLK activity, it is likely that both substrate preference and the amount of lipid phosphate generated in vivo may vary from those measured in vitro. This feature is not unique to MuLK; for example, E. coli DG kinase expressed in mammalian cells causes large increases in ceramide 1-phosphate levels, rather than phosphatidic acid (38) . The more pronounced effect of cardiolipin on ceramide (vs. DG) kinase activity suggests that MuLK's product(s) could change with alterations in its lipid environment.
In addition to phosphorylation of DG and ceramide, our results indicate that MuLK also demonstrates measurable phosphorylation of sn-1 monoacylglycerols. Given that we did not optimize the assay for that substrate, it raises the possibility that lysophosphatidic acids, which are ligands for G-protein coupled receptors (2, 3) , may have a source other than phospholipases A1/A2 or lyso-phospholipase D (39) . Further, MuLK phosphorylation of 2-AG, an endogenous cannabinoid, raises the possibility that MuLK could act in that signaling pathway as well.
Finally, the finding that MuLK activity is inhibited by sphingosine indicates that MuLK representative of three experiments. Kinetic parameters were generated using Prism Graph Pad.
B and C)
Surface dilution analysis of MuLK activity toward 0.8 mM long chain ceramides (B) or 2 mM dioleoylgylcerol (C) was determined in Triton X-100 micelles containing cardiolipin at one tenth the total concentration of substrate, as described under Experimental Procedures.
Kinetic parameters were generated using Prism Graph Pad. Data shown are the average of duplicates +/-the range and are representative of two experiments. 
